| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 49 | 2023 | 269 | 8.880 |
Why?
|
| Insulin Resistance | 29 | 2021 | 411 | 5.320 |
Why?
|
| Obesity | 33 | 2025 | 1248 | 4.800 |
Why?
|
| Insulin | 37 | 2022 | 686 | 4.620 |
Why?
|
| Lipogenesis | 12 | 2023 | 68 | 3.950 |
Why?
|
| Adipose Tissue | 21 | 2022 | 297 | 3.940 |
Why?
|
| Thermogenesis | 9 | 2023 | 122 | 3.050 |
Why?
|
| Lipolysis | 11 | 2023 | 47 | 2.720 |
Why?
|
| Signal Transduction | 34 | 2023 | 3070 | 2.700 |
Why?
|
| Adipose Tissue, White | 12 | 2020 | 87 | 2.410 |
Why?
|
| Mice | 82 | 2025 | 11003 | 2.310 |
Why?
|
| Animals | 102 | 2025 | 20962 | 2.200 |
Why?
|
| Macrophages | 14 | 2020 | 1053 | 2.080 |
Why?
|
| Energy Metabolism | 9 | 2023 | 384 | 2.040 |
Why?
|
| Adipose Tissue, Brown | 9 | 2020 | 119 | 1.930 |
Why?
|
| Adipocytes, Brown | 4 | 2021 | 45 | 1.930 |
Why?
|
| Inflammation | 16 | 2021 | 1162 | 1.880 |
Why?
|
| Intra-Abdominal Fat | 6 | 2019 | 35 | 1.810 |
Why?
|
| Glucose Transporter Type 4 | 16 | 2011 | 60 | 1.740 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2022 | 709 | 1.730 |
Why?
|
| Liver | 9 | 2024 | 868 | 1.700 |
Why?
|
| Fatty Acids | 9 | 2025 | 202 | 1.690 |
Why?
|
| Triglycerides | 8 | 2021 | 244 | 1.630 |
Why?
|
| RNA, Small Interfering | 22 | 2024 | 927 | 1.590 |
Why?
|
| Mice, Inbred C57BL | 31 | 2025 | 3450 | 1.570 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2016 | 343 | 1.570 |
Why?
|
| Lipid Metabolism | 8 | 2025 | 223 | 1.520 |
Why?
|
| Insulin-Secreting Cells | 7 | 2021 | 189 | 1.460 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2016 | 210 | 1.440 |
Why?
|
| Atherosclerosis | 4 | 2017 | 156 | 1.430 |
Why?
|
| Adipocytes, Beige | 3 | 2020 | 15 | 1.430 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 91 | 1.420 |
Why?
|
| 3T3-L1 Cells | 24 | 2016 | 90 | 1.410 |
Why?
|
| Mice, Obese | 12 | 2024 | 80 | 1.400 |
Why?
|
| Adipocytes, White | 3 | 2021 | 27 | 1.370 |
Why?
|
| Glucose Intolerance | 5 | 2021 | 90 | 1.350 |
Why?
|
| PPAR gamma | 9 | 2009 | 77 | 1.320 |
Why?
|
| Gene Silencing | 10 | 2015 | 405 | 1.210 |
Why?
|
| Pericardium | 3 | 2019 | 35 | 1.170 |
Why?
|
| Glucose | 15 | 2019 | 471 | 1.160 |
Why?
|
| Fatty Liver | 6 | 2021 | 109 | 1.150 |
Why?
|
| Muscle Proteins | 6 | 2004 | 117 | 1.150 |
Why?
|
| RNA Interference | 11 | 2013 | 618 | 1.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2022 | 22 | 1.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2017 | 617 | 1.110 |
Why?
|
| Monosaccharide Transport Proteins | 6 | 2004 | 43 | 1.050 |
Why?
|
| Fatty Acid Synthases | 4 | 2023 | 24 | 1.030 |
Why?
|
| Mice, Knockout | 17 | 2023 | 2140 | 1.000 |
Why?
|
| Carrier Proteins | 8 | 2013 | 709 | 0.960 |
Why?
|
| Autophagy | 3 | 2023 | 231 | 0.950 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2016 | 125 | 0.910 |
Why?
|
| Endothelial Cells | 2 | 2017 | 193 | 0.900 |
Why?
|
| Gene Expression Regulation | 12 | 2015 | 1621 | 0.880 |
Why?
|
| Cell Membrane | 10 | 2011 | 501 | 0.870 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 283 | 0.840 |
Why?
|
| Adipogenesis | 4 | 2011 | 79 | 0.810 |
Why?
|
| beta-Glucans | 2 | 2016 | 56 | 0.800 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2023 | 17 | 0.800 |
Why?
|
| Autophagosomes | 1 | 2023 | 13 | 0.790 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 142 | 0.780 |
Why?
|
| Phosphoproteins | 6 | 2011 | 221 | 0.760 |
Why?
|
| Phosphorylation | 17 | 2019 | 948 | 0.760 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2011 | 151 | 0.750 |
Why?
|
| Blood Vessels | 2 | 2014 | 63 | 0.750 |
Why?
|
| Obesity, Morbid | 2 | 2016 | 97 | 0.730 |
Why?
|
| Drug Delivery Systems | 4 | 2021 | 329 | 0.730 |
Why?
|
| Catecholamines | 2 | 2022 | 31 | 0.730 |
Why?
|
| Humans | 61 | 2025 | 64279 | 0.720 |
Why?
|
| Actins | 5 | 2011 | 261 | 0.720 |
Why?
|
| Cells, Cultured | 13 | 2017 | 2177 | 0.710 |
Why?
|
| Male | 38 | 2025 | 30323 | 0.710 |
Why?
|
| Nuclear Proteins | 7 | 2014 | 785 | 0.700 |
Why?
|
| Proteins | 5 | 2010 | 760 | 0.690 |
Why?
|
| Kupffer Cells | 3 | 2017 | 43 | 0.690 |
Why?
|
| Uncoupling Protein 1 | 7 | 2020 | 50 | 0.690 |
Why?
|
| Blood Glucose | 5 | 2017 | 487 | 0.680 |
Why?
|
| Myosins | 4 | 2008 | 115 | 0.680 |
Why?
|
| Sympathetic Nervous System | 2 | 2019 | 35 | 0.670 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 178 | 0.670 |
Why?
|
| Up-Regulation | 6 | 2020 | 375 | 0.650 |
Why?
|
| CRISPR-Cas Systems | 2 | 2021 | 364 | 0.650 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 15 | 0.650 |
Why?
|
| Cell Differentiation | 9 | 2021 | 1365 | 0.650 |
Why?
|
| RNA | 3 | 2020 | 429 | 0.640 |
Why?
|
| Interleukin-1beta | 5 | 2017 | 271 | 0.630 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 80 | 0.620 |
Why?
|
| Ion Channels | 3 | 2016 | 92 | 0.610 |
Why?
|
| Mitochondrial Proteins | 4 | 2016 | 106 | 0.610 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 122 | 0.600 |
Why?
|
| Osteopontin | 2 | 2016 | 21 | 0.580 |
Why?
|
| Peptide Fragments | 4 | 2016 | 417 | 0.580 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 324 | 0.580 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 329 | 0.580 |
Why?
|
| Endocytosis | 3 | 2004 | 153 | 0.570 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 320 | 0.570 |
Why?
|
| Biological Transport | 10 | 2008 | 291 | 0.560 |
Why?
|
| Gene Targeting | 1 | 2018 | 77 | 0.560 |
Why?
|
| Adiposity | 3 | 2018 | 83 | 0.560 |
Why?
|
| Mitochondria | 9 | 2025 | 384 | 0.550 |
Why?
|
| Diet, High-Fat | 5 | 2025 | 176 | 0.540 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2008 | 174 | 0.540 |
Why?
|
| Chylous Ascites | 1 | 2017 | 2 | 0.540 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 848 | 0.530 |
Why?
|
| Lymphangiogenesis | 1 | 2017 | 14 | 0.530 |
Why?
|
| Norepinephrine | 1 | 2017 | 103 | 0.520 |
Why?
|
| MAP Kinase Signaling System | 4 | 2013 | 231 | 0.520 |
Why?
|
| Genetic Therapy | 2 | 2016 | 802 | 0.500 |
Why?
|
| Chylothorax | 1 | 2016 | 2 | 0.500 |
Why?
|
| Macrophages, Peritoneal | 2 | 2016 | 78 | 0.500 |
Why?
|
| Lipid Droplets | 1 | 2016 | 34 | 0.490 |
Why?
|
| Multiprotein Complexes | 2 | 2016 | 155 | 0.480 |
Why?
|
| Amines | 1 | 2016 | 30 | 0.480 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 32 | 0.470 |
Why?
|
| Cyclic AMP | 3 | 2022 | 145 | 0.460 |
Why?
|
| Extracellular Traps | 1 | 2015 | 44 | 0.450 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 50 | 0.450 |
Why?
|
| Vascular Diseases | 1 | 2015 | 82 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2015 | 106 | 0.440 |
Why?
|
| Gene Deletion | 2 | 2015 | 312 | 0.430 |
Why?
|
| Protein Kinases | 3 | 2014 | 153 | 0.430 |
Why?
|
| 3T3 Cells | 9 | 2009 | 112 | 0.430 |
Why?
|
| Membrane Proteins | 2 | 2016 | 909 | 0.420 |
Why?
|
| Wound Healing | 1 | 2015 | 192 | 0.420 |
Why?
|
| Hepatocytes | 4 | 2022 | 220 | 0.420 |
Why?
|
| Protein Structure, Tertiary | 12 | 2011 | 674 | 0.410 |
Why?
|
| Cytokines | 6 | 2017 | 944 | 0.410 |
Why?
|
| Subcutaneous Fat | 3 | 2021 | 47 | 0.410 |
Why?
|
| Transcription Factors | 4 | 2016 | 1540 | 0.400 |
Why?
|
| CD40 Antigens | 1 | 2013 | 60 | 0.390 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2012 | 6 | 0.390 |
Why?
|
| Palmitates | 2 | 2023 | 21 | 0.390 |
Why?
|
| E-Selectin | 1 | 2012 | 18 | 0.390 |
Why?
|
| Acetyl Coenzyme A | 2 | 2023 | 24 | 0.390 |
Why?
|
| Receptors, Notch | 1 | 2013 | 106 | 0.390 |
Why?
|
| Hypoxia | 2 | 2025 | 116 | 0.380 |
Why?
|
| Cell Line | 8 | 2018 | 2055 | 0.370 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 94 | 0.370 |
Why?
|
| Myoblasts | 1 | 2012 | 64 | 0.370 |
Why?
|
| Glucose Tolerance Test | 4 | 2017 | 97 | 0.360 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 205 | 0.360 |
Why?
|
| Microscopy, Fluorescence | 7 | 2013 | 402 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 544 | 0.350 |
Why?
|
| Diet | 3 | 2013 | 533 | 0.350 |
Why?
|
| Stem Cells | 3 | 2025 | 262 | 0.350 |
Why?
|
| MicroRNAs | 3 | 2011 | 697 | 0.340 |
Why?
|
| Phagocytes | 1 | 2011 | 52 | 0.340 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 110 | 0.340 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 2238 | 0.340 |
Why?
|
| Enzyme Activation | 6 | 2013 | 386 | 0.340 |
Why?
|
| Isoproterenol | 1 | 2010 | 37 | 0.340 |
Why?
|
| COS Cells | 5 | 2011 | 174 | 0.340 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2008 | 51 | 0.330 |
Why?
|
| Cell Proliferation | 7 | 2019 | 1001 | 0.330 |
Why?
|
| Body Mass Index | 4 | 2012 | 874 | 0.330 |
Why?
|
| Islets of Langerhans | 3 | 2017 | 280 | 0.330 |
Why?
|
| Protein Transport | 8 | 2011 | 405 | 0.330 |
Why?
|
| Omentum | 1 | 2010 | 15 | 0.320 |
Why?
|
| Models, Biological | 8 | 2009 | 1187 | 0.320 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 1997 | 0.320 |
Why?
|
| Clathrin | 2 | 2007 | 23 | 0.320 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 644 | 0.310 |
Why?
|
| Gene Expression | 6 | 2014 | 851 | 0.310 |
Why?
|
| Blotting, Western | 5 | 2016 | 614 | 0.300 |
Why?
|
| Clonal Anergy | 2 | 2009 | 23 | 0.300 |
Why?
|
| Cell Membrane Structures | 2 | 2008 | 9 | 0.290 |
Why?
|
| Flow Cytometry | 3 | 2017 | 668 | 0.280 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 1297 | 0.280 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 9 | 0.270 |
Why?
|
| Caspases | 1 | 2009 | 176 | 0.270 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 1196 | 0.270 |
Why?
|
| Membrane Fusion | 2 | 2007 | 68 | 0.270 |
Why?
|
| Homeostasis | 4 | 2019 | 370 | 0.270 |
Why?
|
| Neurons | 3 | 2018 | 934 | 0.270 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 13 | 0.270 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 1597 | 0.260 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 23 | 0.260 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2017 | 15 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 28 | 0.260 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2019 | 297 | 0.260 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2016 | 431 | 0.260 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 221 | 0.260 |
Why?
|
| RNA, Complementary | 2 | 2006 | 19 | 0.260 |
Why?
|
| Phosphatidylinositols | 2 | 2007 | 52 | 0.260 |
Why?
|
| RNA, Messenger | 9 | 2011 | 1551 | 0.260 |
Why?
|
| Fatty Acid Synthase, Type I | 2 | 2018 | 5 | 0.250 |
Why?
|
| Osteoblasts | 2 | 2025 | 201 | 0.250 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 234 | 0.250 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 645 | 0.250 |
Why?
|
| Cytoskeleton | 2 | 2004 | 139 | 0.250 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 2 | 0.240 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 4 | 2016 | 21 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 217 | 0.240 |
Why?
|
| Gene Editing | 2 | 2021 | 324 | 0.240 |
Why?
|
| Qb-SNARE Proteins | 1 | 2005 | 4 | 0.240 |
Why?
|
| Oxidative Phosphorylation | 1 | 2005 | 41 | 0.240 |
Why?
|
| Diabetes Mellitus | 4 | 2021 | 541 | 0.230 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 747 | 0.230 |
Why?
|
| Myosin Type I | 4 | 2008 | 7 | 0.230 |
Why?
|
| Intestinal Mucosa | 2 | 2019 | 243 | 0.220 |
Why?
|
| Ubiquinone | 1 | 2025 | 20 | 0.220 |
Why?
|
| Fibroblasts | 4 | 2010 | 404 | 0.220 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2004 | 17 | 0.220 |
Why?
|
| Glucose Clamp Technique | 2 | 2016 | 57 | 0.220 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 41 | 0.220 |
Why?
|
| Epididymis | 2 | 2016 | 26 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 132 | 0.220 |
Why?
|
| Dietary Fats | 3 | 2016 | 175 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 209 | 0.220 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2024 | 12 | 0.210 |
Why?
|
| Myogenic Regulatory Factor 5 | 2 | 2015 | 16 | 0.210 |
Why?
|
| Phospholipids | 2 | 2023 | 82 | 0.210 |
Why?
|
| Collagen Type I | 1 | 2024 | 42 | 0.210 |
Why?
|
| Proteoglycans | 2 | 2016 | 32 | 0.210 |
Why?
|
| Hepatic Stellate Cells | 1 | 2024 | 24 | 0.210 |
Why?
|
| Bone and Bones | 1 | 2025 | 145 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 104 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 153 | 0.210 |
Why?
|
| Collagen | 1 | 2024 | 124 | 0.200 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 115 | 0.200 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 396 | 0.200 |
Why?
|
| Fibrosis | 2 | 2021 | 162 | 0.200 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 11 | 0.190 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2022 | 9 | 0.190 |
Why?
|
| Oxygen | 4 | 2025 | 321 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 224 | 0.190 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2022 | 17 | 0.190 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 180 | 0.190 |
Why?
|
| Substrate Specificity | 5 | 2011 | 340 | 0.180 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 761 | 0.180 |
Why?
|
| Lysosomes | 1 | 2023 | 169 | 0.180 |
Why?
|
| Multienzyme Complexes | 1 | 2022 | 88 | 0.180 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 298 | 0.180 |
Why?
|
| Plasmids | 2 | 2018 | 293 | 0.180 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2021 | 12 | 0.180 |
Why?
|
| Microtubules | 1 | 2003 | 210 | 0.180 |
Why?
|
| RNAi Therapeutics | 1 | 2021 | 11 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2008 | 149 | 0.180 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 30 | 0.180 |
Why?
|
| Cholesterol Ester Storage Disease | 1 | 2021 | 1 | 0.170 |
Why?
|
| Wolman Disease | 1 | 2021 | 1 | 0.170 |
Why?
|
| Exocytosis | 3 | 2007 | 59 | 0.170 |
Why?
|
| Thiazolidinediones | 3 | 2008 | 50 | 0.170 |
Why?
|
| NF-kappa B | 2 | 2015 | 471 | 0.170 |
Why?
|
| Neuregulins | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 183 | 0.160 |
Why?
|
| Denervation | 1 | 2020 | 19 | 0.160 |
Why?
|
| Body Temperature Regulation | 2 | 2018 | 21 | 0.160 |
Why?
|
| Cold Temperature | 1 | 2020 | 51 | 0.160 |
Why?
|
| Cell Polarity | 1 | 2020 | 109 | 0.160 |
Why?
|
| Yeasts | 1 | 2000 | 49 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2020 | 119 | 0.160 |
Why?
|
| Time Factors | 7 | 2008 | 3726 | 0.160 |
Why?
|
| Chemokine CCL2 | 3 | 2017 | 57 | 0.150 |
Why?
|
| Peptides | 3 | 2016 | 590 | 0.150 |
Why?
|
| Female | 11 | 2021 | 33382 | 0.150 |
Why?
|
| Fungal Proteins | 1 | 2000 | 149 | 0.150 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2010 | 40 | 0.150 |
Why?
|
| Lipopolysaccharides | 4 | 2012 | 625 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 429 | 0.150 |
Why?
|
| Hyperglycemia | 2 | 2017 | 105 | 0.140 |
Why?
|
| Trans-Activators | 2 | 2014 | 312 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2019 | 209 | 0.140 |
Why?
|
| Cell Communication | 1 | 2019 | 132 | 0.140 |
Why?
|
| Indoles | 2 | 2009 | 115 | 0.140 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 6 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2019 | 67 | 0.140 |
Why?
|
| Perilipin-1 | 2 | 2008 | 11 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 495 | 0.140 |
Why?
|
| Phenotype | 2 | 2020 | 1222 | 0.140 |
Why?
|
| Middle Aged | 7 | 2019 | 17923 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2018 | 260 | 0.140 |
Why?
|
| Rats | 5 | 2017 | 2005 | 0.130 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 13 | 0.130 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 35 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 101 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 41 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 68 | 0.130 |
Why?
|
| Antigen Presentation | 1 | 2019 | 241 | 0.130 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2016 | 53 | 0.130 |
Why?
|
| Electron Transport | 2 | 2025 | 36 | 0.130 |
Why?
|
| Proteomics | 2 | 2011 | 294 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 38 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 117 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 128 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2017 | 112 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 143 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2017 | 203 | 0.120 |
Why?
|
| Sirolimus | 2 | 2008 | 94 | 0.120 |
Why?
|
| Kinetics | 2 | 2009 | 766 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 2 | 2008 | 68 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1164 | 0.120 |
Why?
|
| Receptors, LDL | 1 | 2015 | 35 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 783 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 901 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2025 | 327 | 0.120 |
Why?
|
| Animals, Newborn | 1 | 2016 | 245 | 0.120 |
Why?
|
| Aminopyridines | 1 | 2015 | 36 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2007 | 165 | 0.120 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 446 | 0.120 |
Why?
|
| Cricetinae | 2 | 2008 | 368 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 205 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 110 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2015 | 42 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 86 | 0.110 |
Why?
|
| Citrulline | 1 | 2015 | 46 | 0.110 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2015 | 88 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 156 | 0.110 |
Why?
|
| Transfection | 3 | 2009 | 695 | 0.110 |
Why?
|
| Hydrolases | 1 | 2015 | 82 | 0.110 |
Why?
|
| Isoenzymes | 2 | 2005 | 141 | 0.110 |
Why?
|
| Lipoprotein Lipase | 1 | 2014 | 13 | 0.110 |
Why?
|
| Collagen Type VI | 1 | 2014 | 1 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 66 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 490 | 0.110 |
Why?
|
| Androstadienes | 2 | 2005 | 41 | 0.110 |
Why?
|
| Regeneration | 1 | 2014 | 101 | 0.100 |
Why?
|
| Protein Binding | 3 | 2011 | 1618 | 0.100 |
Why?
|
| Transferrin | 2 | 2004 | 70 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 239 | 0.100 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2013 | 5 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 666 | 0.100 |
Why?
|
| Arachidonic Acids | 1 | 2013 | 27 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2018 | 374 | 0.100 |
Why?
|
| Endocannabinoids | 1 | 2013 | 22 | 0.100 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 130 | 0.100 |
Why?
|
| Aging | 1 | 2019 | 754 | 0.100 |
Why?
|
| Osteogenesis | 2 | 2025 | 149 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 85 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 191 | 0.100 |
Why?
|
| Blood Proteins | 2 | 2010 | 80 | 0.090 |
Why?
|
| Muscle Development | 1 | 2012 | 56 | 0.090 |
Why?
|
| Prediabetic State | 1 | 2012 | 53 | 0.090 |
Why?
|
| Apoptosis | 3 | 2013 | 1094 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 365 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 458 | 0.090 |
Why?
|
| Adrenal Glands | 1 | 2012 | 33 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2013 | 266 | 0.090 |
Why?
|
| Binding Sites | 4 | 2011 | 914 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 373 | 0.090 |
Why?
|
| Immune System | 1 | 2012 | 131 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 12 | 0.090 |
Why?
|
| Base Sequence | 3 | 2009 | 1332 | 0.090 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 144 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 64 | 0.090 |
Why?
|
| Microcirculation | 1 | 2011 | 54 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 77 | 0.090 |
Why?
|
| Endoribonucleases | 1 | 2011 | 56 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 136 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 61 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 58 | 0.080 |
Why?
|
| Adult | 5 | 2016 | 17133 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 500 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 128 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2010 | 113 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 112 | 0.080 |
Why?
|
| Lipase | 1 | 2010 | 52 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 141 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 84 | 0.080 |
Why?
|
| Neutrophils | 1 | 2012 | 378 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 497 | 0.080 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 29 | 0.080 |
Why?
|
| Chemokines | 1 | 2010 | 93 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 216 | 0.080 |
Why?
|
| Protein Stability | 1 | 2009 | 93 | 0.080 |
Why?
|
| Sulfonylurea Compounds | 1 | 2009 | 12 | 0.080 |
Why?
|
| Lipodystrophy | 1 | 2009 | 11 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2013 | 342 | 0.080 |
Why?
|
| Particle Size | 1 | 2011 | 421 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 704 | 0.080 |
Why?
|
| Prognosis | 1 | 2014 | 1769 | 0.080 |
Why?
|
| Ribonuclease III | 2 | 2011 | 87 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2006 | 85 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2009 | 47 | 0.070 |
Why?
|
| Caspase 6 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 58 | 0.070 |
Why?
|
| Dimerization | 2 | 2006 | 146 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 518 | 0.070 |
Why?
|
| Glucans | 1 | 2009 | 66 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2009 | 65 | 0.070 |
Why?
|
| Acetamides | 1 | 2008 | 13 | 0.070 |
Why?
|
| Transport Vesicles | 2 | 2011 | 14 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2009 | 196 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 85 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 152 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2009 | 108 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 136 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2009 | 167 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 1176 | 0.070 |
Why?
|
| Paxillin | 1 | 2008 | 9 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 56 | 0.070 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2008 | 11 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 24 | 0.070 |
Why?
|
| Aged | 3 | 2019 | 14664 | 0.070 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cell Survival | 2 | 2013 | 582 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 186 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 62 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 30 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 150 | 0.070 |
Why?
|
| Deoxyglucose | 2 | 2005 | 32 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 2049 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 704 | 0.060 |
Why?
|
| Risk Factors | 2 | 2014 | 5342 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 153 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2005 | 303 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 251 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 869 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 567 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 15 | 0.060 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 27 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 14 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2009 | 396 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 22 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2005 | 29 | 0.060 |
Why?
|
| trans-Golgi Network | 1 | 2005 | 8 | 0.060 |
Why?
|
| Glycolysis | 1 | 2005 | 57 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2007 | 325 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 94 | 0.060 |
Why?
|
| Adiponectin | 1 | 2005 | 37 | 0.060 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2005 | 5 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 883 | 0.060 |
Why?
|
| Thymidine | 1 | 2005 | 25 | 0.060 |
Why?
|
| Trypsin | 1 | 2005 | 42 | 0.060 |
Why?
|
| Succinate Dehydrogenase | 1 | 2025 | 15 | 0.060 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 35 | 0.060 |
Why?
|
| Fumarates | 1 | 2025 | 10 | 0.060 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 59 | 0.060 |
Why?
|
| Electrons | 1 | 2025 | 36 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 50 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 183 | 0.060 |
Why?
|
| Phospholipase C delta | 1 | 2004 | 4 | 0.060 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2004 | 8 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 206 | 0.060 |
Why?
|
| CD3 Complex | 1 | 2004 | 65 | 0.060 |
Why?
|
| CD28 Antigens | 1 | 2004 | 60 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 319 | 0.060 |
Why?
|
| Inositol Phosphates | 1 | 2004 | 17 | 0.060 |
Why?
|
| Clone Cells | 1 | 2004 | 116 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2004 | 27 | 0.050 |
Why?
|
| Cholesterol | 1 | 2006 | 260 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2005 | 103 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 2004 | 2 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2004 | 34 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2004 | 8 | 0.050 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2004 | 7 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2482 | 0.050 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2004 | 66 | 0.050 |
Why?
|
| Ligands | 1 | 2006 | 417 | 0.050 |
Why?
|
| Chromones | 1 | 2004 | 19 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 72 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 58 | 0.050 |
Why?
|
| Molecular Motor Proteins | 1 | 2004 | 33 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2004 | 103 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 430 | 0.050 |
Why?
|
| CHO Cells | 1 | 2004 | 189 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 20 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 90 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 204 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2005 | 348 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2004 | 130 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 374 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 35 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 296 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 50 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 291 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 203 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 131 | 0.050 |
Why?
|
| Thiazoles | 1 | 2003 | 47 | 0.050 |
Why?
|
| Cell Division | 2 | 2014 | 454 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2003 | 261 | 0.050 |
Why?
|
| Endosomes | 1 | 2003 | 178 | 0.050 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2002 | 7 | 0.050 |
Why?
|
| Organic Anion Transporters | 1 | 2002 | 6 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 375 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2002 | 27 | 0.050 |
Why?
|
| Actin-Related Protein 2 | 1 | 2001 | 6 | 0.050 |
Why?
|
| Actin-Related Protein 3 | 1 | 2001 | 6 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 685 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 7 | 0.050 |
Why?
|
| Oxygen Consumption | 3 | 2008 | 212 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 2021 | 10 | 0.040 |
Why?
|
| Sterol Esterase | 1 | 2021 | 6 | 0.040 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 14 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 41 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2004 | 632 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 176 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 235 | 0.040 |
Why?
|
| Liver X Receptors | 2 | 2011 | 8 | 0.040 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2011 | 6 | 0.040 |
Why?
|
| Mutation | 1 | 2008 | 2629 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 671 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2011 | 540 | 0.040 |
Why?
|
| Sitagliptin Phosphate | 1 | 2018 | 2 | 0.040 |
Why?
|
| Caveolin 1 | 1 | 2018 | 8 | 0.040 |
Why?
|
| Receptor, PAR-2 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Factor Xa | 1 | 2018 | 5 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 685 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2021 | 270 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 182 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2010 | 6742 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 40 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 32 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 775 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2017 | 7 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 43 | 0.030 |
Why?
|
| Glycine | 2 | 2008 | 50 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 96 | 0.030 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2016 | 7 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 7 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 94 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2017 | 190 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5528 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2007 | 436 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1494 | 0.030 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 3 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 679 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 36 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 627 | 0.030 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2013 | 8 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 174 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 116 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 51 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 356 | 0.020 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 260 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 22 | 0.020 |
Why?
|
| Thioglycolates | 1 | 2011 | 7 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2011 | 5 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2012 | 65 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 17 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 35 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 38 | 0.020 |
Why?
|
| Peritonitis | 1 | 2011 | 43 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 97 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 80 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 379 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2011 | 76 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 83 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 319 | 0.020 |
Why?
|
| Columbidae | 1 | 2009 | 12 | 0.020 |
Why?
|
| Leukemia | 1 | 2009 | 60 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 28 | 0.020 |
Why?
|
| Pedigree | 1 | 2009 | 195 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 433 | 0.020 |
Why?
|
| Transplantation Tolerance | 1 | 2009 | 69 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 24 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2009 | 62 | 0.020 |
Why?
|
| Carcinoma | 1 | 2009 | 129 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 295 | 0.020 |
Why?
|
| Antigens | 1 | 2009 | 149 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2009 | 199 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1431 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 580 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2008 | 34 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 45 | 0.020 |
Why?
|
| Longevity | 1 | 2009 | 116 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 155 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 146 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 197 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2008 | 110 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 891 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1570 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 430 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 625 | 0.010 |
Why?
|
| Crystallization | 1 | 2005 | 101 | 0.010 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2005 | 3 | 0.010 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2005 | 8 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2005 | 21 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 46 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 3318 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 46 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 2004 | 15 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 68 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 46 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 248 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1159 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6305 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4781 | 0.010 |
Why?
|